Evaluation of Once-Daily PRM125 On Ambulatory Blood Pressure in Adults With Hypertension
Latest Information Update: 23 Mar 2023
At a glance
- Drugs PRM-125 (Primary)
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors PRM Pharma
- 16 Mar 2023 Status changed from recruiting to withdrawn prior to enrolment.
- 25 Jan 2022 New trial record